Key points are not available for this paper at this time.
The increased understanding of the immune mechanisms of rheumatoid arthritis has led to the development of a considerable number of new therapeutic agents that alter the natural history of the disease and reduce mortality.
McInnes et al. (Wed,) studied this question.